Infusion Drug Delivery Resources
-
Bag Flling Is Now Possible In The United States
2/10/2023
Explore the reasons why one CDMO is expanding its operations to offer flexible bag filling, after being equipped with filling lines for PFS and glass vials (glass or plastic).
-
Contract Design And Development Vs. In-House: How To Find The Best Fit
3/21/2024
Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.
-
Delivering The Promise Of Gene Therapy
1/22/2024
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
-
Solubility With Lipid-Based Technologies For Oral & Injectable Formulations
11/7/2022
Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.
-
Accelerating Gene Therapy With HITSCAN Platform
4/16/2025
Battelle’s HIT SCAN™ platform accelerates gene therapy by rapidly designing, screening, and optimizing nanoparticle drug delivery systems using high-throughput robotics and machine learning.
-
Wearable Injectors: An Alternative To Traditional Intravenous Administration
3/24/2022
See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.
-
Navigating Regulatory Challenges In Oligonucleotide Therapeutics
12/12/2024
Oligonucleotide therapies offer precise treatments for genetic disorders and chronic diseases. They face unique regulatory challenges but hold great promise, especially when combined with FDA engagement.
-
Rational Design And Development Of Long-Acting Injectable Dosage Forms
1/26/2022
The increasing prevalence of chronic disorders, growing demand for self-administration, and the increasing demand for minimally invasive surgeries have fueled the growth of the LAI drug delivery market.
-
High-Throughput Platform Propels Gene Editing Therapy Research
3/1/2024
Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.
-
Small Is Powerful And Sustained
Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.